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ABSTRACT
Herpes simplex virus type 1 expresses five immediate-
early (IE) polypeptides. In the absence of functional
Vmw175 (the product of IE gene 3) activation of
transcription of later classes of viral genes and
repression of IE gene expression does not occur. The
recognition of specific DNA sequences by Vmw175
requires, as determined by sensitivity to mutation, a
part of the protein highly conserved in the
corresponding proteins of related herpes viruses.
However, mutations in other parts of the protein can
also disrupt specific DNA binding. This paper shows
that the DNA binding domain of Vmw175 can be
liberated as a functional unit by digestion with
proteinase K. Analysis of mutant Vmw175 proteins
showed that the proteinase K resistant domain has an
amino terminus between amino acid residues 229 and
292, while its carboxy terminus is between residues 495
and 518. Mutations outside this region which affect
DNA binding by the intact protein do not eliminate
binding of the proteinase K resistant domain. This
implies that direct DNA binding by Vmw175 involves
a linear subsection of the polypeptide, and that
mutations in other parts of the polypeptide which affect
DNA binding of the whole protein do so by indirect
means.
INTRODUCTION
Herpes simplex virus type 1 (HSV-1) is a common human
pathogen with a double stranded DNA genome of 150kb, the
complete sequence of which is known (1). The genome includes
at least 70 distinct open reading frames, which are expressed from
transcripts that can be divided into three main temporal classes,
immediate-early (IE), early and late (for reviews see references
2 and 3). Four of the five IE polypeptides have some role in
subsequent viral gene regulation, but perhaps the most important
is the product of IE gene 3, Vmwl75 (or ICP4). Viruses with
temperature sensitive (ts) lesions in Vmwl75 are generally
inefficient or completely unable to activate transcription of later
classes of genes, and are unable to repress IE gene expression
at non permissive temperature (npt) (4 — 8). Viruses with ts and
deletion mutations in Vmwl75 fail to form plaques on normal
tissue culture cells at npt. Thus Vmwl75 plays a central and
crucial role in the regulation of HSV-1 gene expression and as
such has been the focus of extensive study.
Vmwl75 is a phosphorylated nuclear protein (9) which can
be poly(ADP)ribosylated in vitro (10) and which migrates as
multiple species on SDS polyacrylamide gels with an approximate
molecular weight of 175kd (11). It is translated from an unspliced
IE-3 transcription unit in the short repeat regions of the viral
genome (Figure 1) and the DNA sequence predicts a translation
product of 1298 amino acid residues (12). The predicted primary
sequence can be divided into five regions on the basis of similarity
to the corresponding proteins expressed by other
alphaherpesviruses (12-14). Regions 2 and 4, composed of
residues 315 to 484 and residues 797 to 1224 respectively, are
the most highly conserved and include the locations of several
ts lesions (6,8,15). Mutagenesis of Vmwl75 has revealed that
regions 2 and 4 are more sensitive to disruption of Vmwl75
function by mutation than other regions (16—22).
Vmwl75 is a sequence specific DNA binding protein which
recognises sites which include the consensus ATCGTC and also
other sites that have been less well defined (23-26). The
relationship of the DNA binding activity of Vmwl75 to its
functions is not completely clear. There is a strong binding site
at the capsite of the IE-3 promoter which is necessary for the
repression of this promoter by Vmwl75 both in transfection
assays (27) and in the viral genome (16). Few of the promoters
that are activated by Vmwl75 contain ATCGTC sequences in
their vicinity (although the presence of other non-consensus sites
can not be excluded). Where Vmwl75 binding sites do occur,
they can contribute to the activation of in vitro transcription by
Vmwl75 (24, 28, 29), but they are not necessary for activation
by Vmwl75 in transfection experiments (28), especially in the
presence of the other HSV IE gene products (30,31). However,
mutational analysis of Vmwl75 clearly shows that mutations in
region 2 which affect transcriptional activation and repression
also affect the ability of Vmwl75 to bind to its recognition
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sequences (8,16,32,33). The implication is that DNA binding
is, in some way as yet poorly understood, important for
transcriptional activation by Vmwl75.
In this study we show that a domain of Vmwl75 capable of
specific DNA binding can be separated from the whole protein
by prior proteinase K digestion. We have defined the part of the
protein involved by analysis of insertion, deletion and ts
mutations; the results show that the distal end of region 1 and
a substantial part or the whole of region 2 are involved in the
formation of the DNA protein complex. In addition, we have
shown that mutations in other parts of the polypeptide which affect
binding of the whole protein do not affect the production or
activity of the proteinase K resistant domain. This raises the
interesting possibility that the properties of the DNA binding
domain of Vmwl75 might be influenced by other sequences in
the whole protein.
MATERIALS AND METHODS
Plasmids and Bacteria
Plasmid pl75 contains the HSV-1 IE-3 transcription unit linked
to the SV40 early promoter and enhancer in a pBR322 vector
(35). All insertion and deletion mutant plasmids were derived
from pi75 as described (17). Plasmids were propagated in
Escherichia coli strain HB101 using standard methods.
Viruses and Cells
HSV-1 Glasgow strain 17 syn+ was the wild type virus from
which all ts mutants were isolated. Mutant tsK, with a single
base substitution in IE gene 3, has been previously characterised
(4,7,15,34). Mutant viruses M211, ttl219, tsl22l, ts\223 and
tsl225 have been described (8). All viruses were propagated in
BHK C13 cells grown in Glasgow modified Eagles medium
(GMEM) supplemented with 10% new born calf serum and 10%
tryptose phosphate broth. HeLa cells, supplied by Flow
Laboratories from the ATCC collection and grown in GMEM
supplemented with 10% foetal calf serum, were infected with
5pfu per cell of wild type and mutant viruses at either permissive
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Figure 1. A map of the HSV-1 genome, the IE genes and IE gene 3. The HSV-1
genome is shown with the positions and orientations of the five IE genes marked.
A portion of the repeated sequences (boxed regions) is shown with the transcription
unit and the coding region of IE gene 3. Conserved regions 2 and 4 of Vmwl75
are also indicated. The partial restriction map of the IE-3 region is from the EcoRI
(E) site at position - 108 relative to the 5' end of the IE-3 RNA to the SstI (S)
site 5' to IE gene 1. The 'a' sequence at the genome joint is shown as a thicker
line. H = HincII, B = BamHI. The insertion and deletion mutant plasmids used
in this study were in a pl75 background, which contains the BamHI (+27) to
SstI (5' of IE-1) fragment linked to the SV40 early promoter and enhancer in a
pBR322 vector.
temperature or npt. Five hours after a 1 hour absorption period
the cells were harvested for extract preparation.
Transfection of tissue culture cells and preparation of cell
extracts
HeLa cells were seeded at 3xlO6 cells in 15ml medium into
90mm culture dishes. The following day 20ug of the relevant
plasmid DNA was transfected into the cells by the method of
Corsalo and Pearson (36). Whole cell extracts were prepared two
days later exactly as described before (32,37).
Analysis of the DNA binding capability of Vmwl75 by gel
retardation
The ability of Vmwl75 to bind to the IE gene 3 capsite region
was assayed using the conditions and probe described by Muller
(25) as described in detail before (32).
Treatment of cell extracts with proteinase K
Incubations of cell extracts for gel retardation assays were set
up as described above and the appropriate amount of proteinase
K added at times and temperatures as indicated in the text. When
proteinase K treatment was carried out prior to the binding
reaction, PMSF was added to 0.2mM to inhibit the protease
before addition of the probe.
Estimation of the amount of Vmwl75 in cell extracts
The amount of Vmwl75 in cell extracts was estimated by an
ELISA technique using the monoclonal antibody 58S, which
recognises an epitope near the carboxy terminus of Vmwl75,
as described before (17,38).
RESULTS
A proteinase K resistant domain of Vmwl75 binds to the IE-3
capsite
Vmwl75 in nuclear extracts binds specifically to DNA sequences
which contain the consensus ATCGTC (23,39), including that
at the capsite of the IE-3 promoter (25,32). Mutational analyses
of the portions of Vmwl75 that are important for this binding
have strongly suggested that conserved region 2 (12) is part of
the DNA binding domain (16,32,33) but the involvement of other
portions of the protein could not be excluded (8,32). Work in
other fields has demonstrated the usefulness of proteinase K in
trimming DNA-bound proteins to leave a resistant core (40,41).
We have used this method to define the region of Vmwl75 which
is closely in association with DNA.
Extracts from mock infected or cells infected with HSV-1 were
prepared for use in gel retardation assays. In a normal binding
experiment the IE-3 capsite probe gives two complexes with mock
infected extracts (b and c) and a further strong complex ('a') with
extracts containing Vmwl75. The presence of Vmwl75 can be
shown by the further retardation of complex 'a' by subsequent
addition of monoclonal antibody 58S (Figure 2a). To investigate
the effect of proteinase K on these protein-DNA complexes
increasing amounts of protease were added after complex
formation and the results analysed on retardation gels. Figure
2b shows that both cell complexes b and c are susceptible to
digestion, giving bands of increased mobility. The infected cell
extracts gave a further strong complex, p, which was present
only when extracts which contained Vmwl75 were used. The
minor band appearing just above p in Figure 2b tracks 5 - 8 is
probably an intermediate digestion product of Vmwl75. Rather
surprisingly, complex p could also be formed by incubation of
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the cell extract with proteinase K before addition of the probe
(Figure 2c). Prior treatment with proteinase K eliminated the
bands derived from the cellular proteins, indicating that the
proteins that form them are partially protected from protease only
when bound to DNA. In most subsequent experiments prior
treatment with 20ng of proteinase K was used since this gave
the highest yield of complex p in this experiment (Figure 2c).
Attempts to identify which parts of Vmwl75 might remain in
complex p by incubation (after inhibiting the proteinase K with
PMSF) with anti-Vmwl75 antisera were not successful (42;
results not shown). However, using a panel of point mutations
in the Vmwl75 binding sequence located upstream of the
glycoprotein gD promoter, it was shown that mutations which
eliminated binding of intact Vmwl75 also severely reduced
binding by the proteolytic fragment (D. Tedder, R.D. Everett
and L.I. Pizer, manuscript in preparation). This confirms that
complex p includes the DNA binding domain of Vmwl75.
Identification of region 2 of Vmwl75 as the DNA binding
domain
Cells which have been transfected with plasmids which express
Vmwl75 contain sufficient amounts of the protein for use in gel
retardation assays (32). The availability of a large number of
insertion and deletion mutants in the Vmwl75 coding region in
such plasmids allows an investigation of which parts of the
polypeptide are present in complex p. The insertion, deletion and
ts mutants that were used in this study are illustrated in Figure
3 and Table 1.
Previous studies have indicated that region 2 of Vmwl75 is
• I 17 '
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most likely to be the DNA binding domain (16,32,33) and
therefore it was considered most likely that this part of the protein
was contained in complex p. When insertion mutants pI8 through
to pI20 were used in binding assays without proteinase K (Figure
4a), normal amounts of the full size complex 'a' was obtained
with pI8, pI9, pI13, pI17, pI19 and pI20. Plasmids pll 1 and pI18
gave reduced amounts of the normal complex while pi 10 gave
a smear. As previously described (32) plasmids pI14, pI15 and
pi 16 were negative. In the previous study plasmid pi 12 was
weakly positive (in the presence of antibody which may stabilise
the complex) whereas here, despite ELISA detectable Vmwl75
in the extract, pi 12 was negative.
After prior proteinase K treatment, complex p was obtained
with some but not all of the insertion mutants. Plasmids pI8, pI9,
pi 10 and pI20 gave normal amounts of complex p while plasmids
pi l l , pi 13 and pi 19 gave reduced amounts. The simplest
interpretation of the failure to form complex p by pi 12, pi 14,
pi 15 and pi 16 is that the insertions are in critical parts of the
DNA binding domain. The protein expressed by plasmid pi 17
is unable to form large amounts of complex p even though the
intact protein binds to DNA quite efficiently (compare Figure
4a and 4b tracks 11). This suggests that the insertion at residue
398 is in the complex p region and either it disrupts the binding
of the proteolytic fragment directly or changes the protein
structure such that the protease is able to remove residues essential
for DNA binding. On the basis of its poor binding, it is likely
that the insertion in pi 18 is also in the complex p region.
Note that protease K treatment frequently (but not always)
resulted in apparently more complex p than the complex 'a'
formed by the intact protein. Because of its smaller size, complex
p is probably more stable in the separation gel than the full size
complex (which often forms a smear, particularly with some of
the mutants, as the protein dissociates during the run).
Alternatively, partially degraded Vmwl75 in the extract (which
might bind but would form a smear) might be reduced to the
normal complex p size by proteinase K and therefore yield a
unique sized complex.
In order to confirm and extend the above results the analysis
was continued using a selection of deletion mutants in the
Vmwl75 coding region (see Figure 3 and Table 1). Deletions
pDl and pD13 gave normal amounts of complex p, thus
1
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Figure 2. A proteolytic fragment of Vmwl75 binds specifically to the IE gene
3 capsite region. A. Extracts from mock infected (MI) and HSV-1 infected (17+)
cells were prepared and incubated with the IE gene 3 probe. Free probe, host
complexes 'b' and 'c' and the Vmwl75 specific complex 'a' are marked. Complex
'a + ' is formed by the further retardation of complex 'a' by the Vmwl75 specific
monoclonal antibody 58S. B. Binding reactions containing the IE-3 probe and mock
infected (tracks 1-4) and HSV-1 infected (tracks 5-8) extracts were further
incubated at room temperature for 10 minutes with proteinase K after the initial
DNA binding reaction. Tracks 1 - 4 and 5 - 8 were incubated with 0, 1 10, and
20ng of protease respectively. Complexes b' and c' are the products of protease
digestion of host complexes b and c, while complex p is derived from digestion
of the Vmwl75 specific complex 'a'. C. An HSV-1 infected extract was incubated
with (tracks 1 -4 ) 20, 10, 1 and 0 ng proteinase K and then incubated with the
IE-3 probe. In track 5, proteinase K (20ng) was present during the binding reaction.
The complexes are labelled as in B.
pD13
pD14
pD15
pO2F
pD3
pD4
pDii
pD12
Figure 3. Insertion and deletion mutations in Vmwl75. The 1298 codon coding
region of Vmwl75 is represented as a horizontal line with the positions of the
insertion mutations used in this study shown as short vertical lines. A number
of the insertion mutants are identified. The extents of the deletion mutants are
also indicated. The precise details of these mutations are given in Table 1.
Conserved regions 2 (codons 315—484) and 4 (codons 797-1224) are also
indicated.
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TABLE 1. The locations of the insertion deletion and temperature sensitive mutations in
Vmwl75 used in this study.
MUTATION
pI8
pI9
pi 10
pill
pI12
pI13
pi 14
pI15
pI16
pI17
pI18
pi 19
pI20
pI21
pI22
pI23
pI24
pI27
pI28
pI29
pI32
pI33
pI34
pD13
pD14
pD15
pDl
pD2F
pD3
pD4
pDll
pD12
tsK
M1211
W1219
M1221
Ml 225
TYPE
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
insertion
deletion
deletion
deletion
deletion
deletion
deletion
deletion
deletion
deletion
ts
ts
ts
ts
ts
ts
LOCATION
229
252
275/276
292/293
310
324
329
337
373
398/399
438/439
494/495
518
561/562
591
649/650
681
803
843/844
934
1066
1098
1133
12-229
72-292
84-292
162-229
495-803
518-591
518-1133
1196-1239
1232-1269
475
—
865
824
966
CHANGE
P/PPNSG
R/PRIRG
PEFG
PEFG
Y/SRIRD
P/PPNSG
Y/SRIRD
P/PPNSG
Y/SRIRD
PEFG
PEFG
PEFG
Y/SRIRD
AG/PELIRG
P/PPNSG
PEFG
S/SPNSG
R/PRIRG
PEFG
Y/SRIRD
P/PPNSG
Y/SRIRD
Y/SRIRD
PPNSG
PEFG
PEFG
PNSG
PEFG
SRIR
SRIRD
PEFG
PNSKLAIR
A/V
-
L/P
T/R
A/T
BINDING
+ + +
+ + +
+ +
+ + +
+ / -
+ + +
-
-
-
+
+
+ + +
+ + +
+ + +
+ / -
+ +
+ / -
+
+ / -
+ / -
+
+
+ +
weak
-
-
+
weak
-
-
+
+
The mutations in Vmwl75 used in this study are shown. The location of the insertion mutants
indicates the residue affected or the site of insertion between two residues. The original
sequence at these locations, and those of the ts mutations, is shown to the left of a slash
with the new sequence to the right. The co-ordinates of the deletions indicate the residues
that have been deleted; those replaced are given in the last column. The details of the
construction and characterisation of these mutations are given in references 8 and 17. The
column labelled binding summarises the DNA binding results obtained previously with intact
insertion or deletion polypeptides (32). Binding was estimated by visual imspection. For
the insertions, - indicates no binding, + / - barely detectable, + to + + + increasing binding
activity to wild type levels. For the deletions, binding is indicated simply a positive, negative
or weak.
eliminating the presence of residues 13 to 229 (Figure 5).
Deletions pD13 and pD14 did not give any detectable complex
p; both have end-points at residue 292, which suggests that some
residues to the amino side of 292 are involved. Deletion pD2F
gave very low amounts of a complex with altered mobility (not
easily seen in this Figure), which suggests that sequences to the
carboxyl side of residue 495 are normally present in the complex
but that they are not essential for DNA binding. Deletion pD3,
and all the other deletions 3 ' to pD3, were all able to form at
least some complex p. Thus residues from 518 onwards are not
present in the complex. Many of these deletions did not give
detectable complexes with the intact protein (Table 1) which
reflects the low amounts of some of them in the extracts (data
not shown) and the apparent stabilisation of binding resulting from
protease digestion discussed above.
Taken together, the results with the insertion and deletion
mutants show that the amino limit of complex p is between
residues 229 and 292 while the carboxyl limit is between residues
495 and 518. Within this region, insertions at residues 229, 252,
275 and 518 have no effect on binding, insertions at residues
292, 324 and 494 cause some reduction while those at 310, 329,
337, 373, 398 and 438 almost or completely eliminate complex
p formation. The mutation sensitive region includes all of region
2 and some of the carboxyl end of region 1.
The amount of Vmwl75 in all the extracts used in these
experiments was determined using an ELISA assay with
monoclonal antibody 58S. The results confirmed that all the
extracts contained Vmwl75, but in variable quantities. Extracts
which gave neither complex p nor a complex with the full size
protein contained at least as much ELISA-detectable Vmwl75
as others which were positive in gel retardation assays (data not
shown). Unfortunately, due to the intrinsic variability of
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1 2 3 4 5 6 7 8 9 10
probe
Figure 5. The effect of deletion mutations in Vmwl75 on the formation of complex
p. Extracts from cell transfected with (tracks 1 - 10 respectively) pl75, pD13,
pD14, pD15, pDl, pD2F, pD3, pD4, pDl 1 and pD12 were treated with proteinase
K and incubated with the IE-3 capsite probe as described in the methods section
and the legend to Figure 4.
1 2 3 4 5
probe
Figure 4. Formation of the protease resistant DNA binding complex by insertion
mutants of Vmwl75. A. The IE-3 capsite probe was incubated with extracts
prepared from cells transfected with (tracks 1 —14 respectively) pl75, pI8 through
pI20. The comlexes with the host proteins b and c, and that with Vmwl75 ('a')
are marked. B. Incubations were performed as in part A except that the extracts
were pre-treated with 20ng of proteinase K at room temperature for 10 minutes
before adding PMSF, cooling on ice and adition of probe. The free probe and
protease resistant complex p are marked.
transfections and uncertainty of the precise consequences of the
mutations on Vmwl75 stability or solubility, it is not possible
to obtain exactly equivalent extracts using all the mutant proteins
presented in this study.
Mutations in regions of Vmwl75 outside the DNA binding
domain can affect the ability of Vmwl75 to bind to DNA
In a previous analysis of the effects of mutations in Vmw 175
on its ability to bind to the IE-3 capsite probe, we found that
certain mutations, distant from the DNA binding region defined
above, could also affect the efficiency of Vmwl75 DNA binding.
Many of these mutations are in conserved region 4 (8,32). Some
of these mutants gave poor, smeared complex formation. We
have reanalysed these mutants by performing the DNA binding
reactions after proteinase K digestion. The results (Figure 6) show
that all the insertion mutants which bound poorly as intact proteins
(pI22, pI24, pI27, pI28, pI29, pI32 and pI33; Table 1) gave
amounts of complex p frequently comparable with that of the
wild type protein. The simplest interpretation of these results is
that mutations in regions 3 and 4 can affect the structure of the
whole protein so as to compromise the function of the DNA
binding domain. The alternative explanation is that the DNA
binding domain involves two or more regions of the polypeptide
that are distant from one another in the primary sequence. This
is very unlikely given the results defining the limits of complex p.
The effect of changes in region 4 on the function of region
probe
1 2 3 4 5 6 7
I
probe
Figure 6. The effect of mutations in regions 3 and 4 of Vmwl75 on the formation
of complex p. A. Protease resistant complexes formed by (tracks 1 - 6 respectively)
extracts from cells transfected with pI21, pI22, pI23, pI24, pl75 and untransfected
cells. B. Protease resistant complexes formed by extracts from cell transfected
with (tracks 1 - 7 respectively) pl75, pI27, pI28, pI29, pI32, pI33 and pI34. The
amount of complex P obtained with pl28 is low in this experiment due to a low
amount of Vmw 175 in the extract. Other extracts of cells transfected with pl28
had higher amounts of Vmwl75 and gave greater amounts of complex P.
2 is also graphically illustrated by the DNA binding properties
of Vmw 175 proteins with ts lesions that map in region 4. The
mutations in viruses ttl211, ttl219, ts 1221, «1223 and «1225
(Table 1) map in the carboxy terminal third of Vmw 175, and
the lesions in tel219, ts\22l and tel225 have been localised in
region 4 by DNA sequence analysis (8). Mutant tsK, with a single
amino acid substitution at residue 475 in region 2 (15), was
 at U
niversity of G
lasgow
 on D
ecem
ber 19, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
4584 Nucleic Acids Research, Vol. 18, No. 15
included in these experiments for comparison. Extracts were
prepared from cells five hours after infection at npt with HSV-1
strain 17 and the six ts viruses. A preliminary experiment
confirmed previous results that all the Vmwl75 proteins
expressed from these viruses bound to the IE-3 capsite probe at
room temperature (Figure 7a), but that only those expressed by
strain 17 and tsl225 were able to bind at 39.5°C (8). After prior
proteinase K treatment, all the extracts formed complex p after
incubation at room temperature (Figure 7a), and all except tsK
also gave complex p after incubation at npt (Figure 7b). These
results show that the position of the lesion in tsK must be in that
part of Vmwl75 which is included in complex p and that the
mutations in region 4, despite their effects on the DNA binding
potential of the intact protein, are not in the minimal DNA binding
domain. Thus single amino acid changes in a part of the protein
distinct from the DNA binding domain can affect DNA binding.
DISCUSSION
The results presented in this paper clearly demonstrate that a
portion of the Vmwl75 polypeptide comprising the distal end
of region 1 and all of conserved region 2 forms a domain of the
protein that is separable from the whole by proteinase K digestion
and which binds to a specific DNA sequence at the capsite of
IE gene 3. The observation that deletions in the Vmwl75 coding
sequence which remove codons 12—229, 518-1133 and
1196 —1269 do not affect the size of complex p shows that none
of these regions form part of protease resistant domain. The
affects of insertions pI12, pI14, pI15, pI16, pI17, pI18 and
mutation tsK indicate (given the other data on the limits of
complex p) that these mutations affect sequences important for
DNA binding. These results are consistent with previous studies
on the location of the DNA binding domain of Vmwl75
(16,32,33). However, because it is not possible to estimate
accurately the size of the protein retained in complex p, it is not
clear if all of the amino acid residues between the estimated limits
of complex are present. Furthermore, these data do not imply
that the whole of the proteolytic fragment is important for DNA
binding since its size is dependent on the location of the protease
sensitive sites and is not affected by the presence of bound DNA.
Indeed, insertion pi 13 is within complex p but does not greatly
affect its ability to bind to DNA. Further definition of the DNA
binding domain of Vmwl75 will require more extensive
mutagenesis of the complex p region.
The basic conclusions of this study have recently been strongly
supported by a study using fragments of Vmwl75 that have been
expressed in bacteria (43). Wu and Wilcox showed that a peptide
including residues 262—490 was sufficient for DNA binding,
that peptides from 262 -464 and 306-490 did not bind to DNA
and that the bacterially expressed polypeptide gave the same DNA
binding footprint as the intact protein (43). Their mapping is
entirely consistent with the data presented here. It should be noted
that our results do not simply duplicate those using the bacterially
expressed protein; formation of complex p by proteolysis reveals
that this region of the protein really is a physically separable
domain of intact Vmwl75 while the bacterial experiments show
that it can be expressed in isolation.
Mutations in regions of Vmwl75 other than those in the
complex p sequence can also affect DNA binding. The effects
of these other sequences must be indirect since their prior removal
by protease allows the formation of a normal complex p. This
illustrates that care must be taken in the interpretation of DNA
1 2 3 4 5 6 7 8 9 101112 131415
probe
probe
1 2 3 4 5
Figure 7. The effect of ts mutations in Vmwl75 on the formation of complex
p at permissive and non-permissive temperature. A. Extracts from cells infected
with HSV-1 strain 17 (tracks 1 and 9), tsK (tracks 2 and 10), W1211 (tracks 3
and 11), M1219 (tracks 4 and 12), W1221 (tracks 5 and 13), M1223 (tracks 6
and 14), M1225 (tracks 7 and 15) and mock infected (track 8) were incubated
with the IE-3 probe either in the absence (tracks 1-8) or the presence (tracks
9-15) of proteinase K. All incubations were performed at room temperature.
B. Extracts from cells infected with strain 17, tsK, ttl211, M1219, «1221, W1223,
ttl 225 or mock infected were treated with proteinase K at room temperature and
then incubated (after addition of PMSF) with the IE-3 probe at 39.5°C. The lesion
in ttK is the only one to affect complex formation. In this experiment the gel
was run at 37°C, which might explain the rather higher than usual mobility of
complex p. Such increased mobility occasionally occurred in other experiments
but was not apparently caused by more extensive protease digestion.
binding data using mutants of Vmwl75. Mutations in the intact
protein may affect DNA binding by indirect conformational or
stability effects, while studies using only a fragment of the protein
may not be entirely relevant to the complete protein during virus
infection. Although a detailed analysis of the complex p region
may allow the definition of the amino acid residues that are
involved in sequence specific DNA recognition, it will be
necessary to study the effects of mutations in these sequences
in the whole protein in order to determine their relevance during
virus infection.
Perhaps the most potentially interesting aspect of this study
is the concept that small changes in conserved region 4 can affect
the function of conserved region 2. Although there may be several
trivial or technical reasons for this (involving protein stability,
solubility or gross conformational change), it is possible that
protein-protein interactions between sequences in region 4 and
other viral or cellular proteins could affect the conformation of
region 4, which might then (in a similar way to the structural
alterations induced by the insertion and ts mutations) affect region
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2. Therefore DNA binding by Vmwl75 could be modulated by
interactions with other transcription factors. Such interactions
might affect the efficiency of promoter activation by Vmwl75,
or even whether a promoter was activated or repressed.
Nucleic Acids Research, Vol. 18, No. 15 4585
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